Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
ENDRA Life Sciences Inc. (NDRA) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 8-K Quarterly results
Docs: "ENDRA Life Sciences Reports Second Quarter 2023 Financial Results and Provides a Business Update",
"# # # 3"
08/10/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
07/25/2023 8-K Quarterly results
07/06/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "ENDRA Life Sciences Announces Adjournment of 2023 Annual Meeting of Stockholders to July 25, 2023"
05/02/2023 8-K Quarterly results
04/18/2023 8-K Quarterly results
12/23/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/19/2022 8-K Quarterly results
12/08/2022 8-K Quarterly results
12/02/2022 8-K Quarterly results
11/14/2022 8-K Quarterly results
09/27/2022 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: "Certificate of Designation of the Series C Preferred Stock of the Company"
08/15/2022 8-K Quarterly results
06/23/2022 8-K Quarterly results
05/12/2022 8-K Quarterly results
04/21/2022 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "ENDRA Life Sciences Raises $8.7 Million in Gross Proceeds Through its At-The-Market Facility"
03/30/2022 8-K Quarterly results
Docs: "ENDRA Life Sciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update"
02/10/2022 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "# # #"
01/07/2022 8-K Investor presentation
Docs: "ENDRA Life Sciences Inc. January 2022 Investor Presentation, furnished herewith"
11/15/2021 8-K Quarterly results
Docs: "ENDRA Life Sciences Reports Third Quarter 2021 Financial Results and Provides Business Update"
08/12/2021 8-K Quarterly results
06/21/2021 8-K Quarterly results
06/15/2021 8-K Quarterly results
06/08/2021 8-K Quarterly results
05/17/2021 8-K Quarterly results
04/27/2021 8-K Results of Operations and Financial Condition, Other Events
03/25/2021 8-K Quarterly results
03/05/2021 8-K Quarterly results
02/19/2021 8-K Quarterly results
02/03/2021 8-K Quarterly results
01/11/2021 8-K Quarterly results
12/30/2020 8-K Other Events
12/21/2020 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Amendment 4 to Collaborative Research Agreement, by and between the Company and General Electric Company",
"ENDRA Life Sciences Extends GE Healthcare Collaboration Agreement for Two Years"
12/18/2020 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Underwriting Agreement",
"Opinion of K&L Gates LLP",
"ENDRA Life Sciences Announces Proposed Public Offering of Common Stock ANN ARBOR, Mich. – ENDRA Life Sciences Inc.",
"ENDRA Life Sciences Announces Pricing of Public Offering of Common Stock ANN ARBOR, Mich. – ENDRA Life Sciences Inc.",
"ENDRA Life Sciences Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option ANN ARBOR, MI / ACCESSWIRE / December 18, 2020 / ENDRA Life Sciences Inc."
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy